{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:19:35Z","timestamp":1769152775249,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12325-023-02573-3","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:02:34Z","timestamp":1687784554000},"page":"3830-3856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analyses of Dupilumab-Related Ocular Adverse Drug Reactions Using the WHO\u2019s VigiBase"],"prefix":"10.1007","volume":"40","author":[{"given":"Eri","family":"Hirai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"issue":"10013","key":"2573_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","volume":"387","author":"D Thaci","year":"2016","unstructured":"Thaci D, Simpson EL, Beck LA, et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet. 2016;387(10013):40\u201352.","journal-title":"Lancet"},{"issue":"2","key":"2573_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.18176\/jiaci.0682","volume":"32","author":"FJ Munoz-Bellido","year":"2022","unstructured":"Munoz-Bellido FJ, Moreno E, Davila I. Dupilumab: a review of present indications and off-label uses. J Investig Allergol Clin Immunol. 2022;32(2):97\u2013115.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"11","key":"2573_CR3","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.3390\/cells10113000","volume":"10","author":"M Iwaszko","year":"2021","unstructured":"Iwaszko M, Bialy S, Bogunia-Kubik K. Significance of interleukin (IL)-4 and IL-13 in inflammatory arthritis. Cells. 2021;10(11):3000.","journal-title":"Cells"},{"issue":"24","key":"2573_CR4","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335\u201348.","journal-title":"N Engl J Med"},{"issue":"3","key":"2573_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jaad.2021.05.013","volume":"86","author":"CM Brumfiel","year":"2022","unstructured":"Brumfiel CM, Patel MH, Zirwas MJ. Development of psoriasis during treatment with dupilumab: a systematic review. J Am Acad Dermatol. 2022;86(3):708\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2573_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jaad.2021.01.012","volume":"84","author":"CE Jo","year":"2021","unstructured":"Jo CE, Finstad A, Georgakopoulos JR, Piguet V, Yeung J, Drucker AM. Facial and neck erythema associated with dupilumab treatment: a systematic review. J Am Acad Dermatol. 2021;84(5):1339\u201347.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2573_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.20138","volume":"185","author":"B Chretien","year":"2021","unstructured":"Chretien B, Dolladille C, Alexandre J, et al. Dupilumab-associated arthralgia: an observational retrospective study in VigiBase(\u00ae). Br J Dermatol. 2021;185(2):464\u20135.","journal-title":"Br J Dermatol"},{"issue":"3","key":"2573_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12016-022-08934-0","volume":"62","author":"A Kychygina","year":"2022","unstructured":"Kychygina A, Cassagne M, Tauber M, et al. Dupilumab-associated adverse events during treatment of allergic diseases. Clin Rev Allergy Immunol. 2022;62(3):519\u201333.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2573_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaad.2020.08.051","volume":"84","author":"AS Halling","year":"2021","unstructured":"Halling AS, Loft N, Silverberg JI, Guttman-Yassky E, Thyssen JP. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis. J Am Acad Dermatol. 2021;84(1):139\u201347.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2573_CR10","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1111\/all.15326","volume":"77","author":"PM Hansen","year":"2022","unstructured":"Hansen PM, Tollenaere MAX, Hedengran A, et al. IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro. Allergy. 2022;77(8):2555\u20138.","journal-title":"Allergy"},{"issue":"4","key":"2573_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.immuni.2016.09.016","volume":"45","author":"SC Huang","year":"2016","unstructured":"Huang SC, Smith AM, Everts B, et al. Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity. 2016;45(4):817\u201330.","journal-title":"Immunity"},{"issue":"3","key":"2573_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjd.20810","volume":"186","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Beck LA, de Bruin WM, et al. Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials. Br J Dermatol. 2022;186(3):453\u201365.","journal-title":"Br J Dermatol"},{"key":"2573_CR13","first-page":"5865","volume":"25","author":"N Mahroum","year":"2021","unstructured":"Mahroum N, Damiani G, Watad A, et al. Higher rates of COVID-19 but less severe infections reported for patients on dupilumab: a big data analysis of the World Health Organization VigiBase. Eur Rev Med Pharmacol Sci. 2021;25:5865\u201370.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2573_CR14","doi-asserted-by":"crossref","unstructured":"Nor\u00e9n GN, Orre R, Bate A. A hit-miss model for duplicate detection in the WHO drug safety database. Proceeding of the eleventh ACM SIGKDD international conference on knowledge discovery in data mining - KDD '05. 2005:459\u2013468.","DOI":"10.1145\/1081870.1081923"},{"issue":"10086","key":"2573_CR15","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","volume":"389","author":"A Blauvelt","year":"2017","unstructured":"Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017;389(10086):2287\u2013303.","journal-title":"Lancet"},{"issue":"5","key":"2573_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"M de Bruin-Weller","year":"2018","unstructured":"de Bruin-Weller M, Tha\u00e7i D, Smith CH, et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAF\u00c9). Br J Dermatol. 2018;178(5):1083\u2013101.","journal-title":"Br J Dermatol"},{"issue":"2","key":"2573_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jamadermatol.2019.3617","volume":"156","author":"M Worm","year":"2020","unstructured":"Worm M, Simpson EL, Thaci D, et al. Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2020;156(2):131\u201343.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2573_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/bjd.17869","volume":"181","author":"B Akinlade","year":"2019","unstructured":"Akinlade B, Guttman-Yassky E, de Bruin-Weller M, et al. Conjunctivitis in dupilumab clinical trials. Br J Dermatol. 2019;181(3):459\u201373.","journal-title":"Br J Dermatol"},{"issue":"5","key":"2573_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","volume":"315","author":"C Bachert","year":"2016","unstructured":"Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469\u201379.","journal-title":"JAMA"},{"issue":"26","key":"2573_CR20","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486\u201396.","journal-title":"N Engl J Med"},{"issue":"1","key":"2573_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","volume":"158","author":"I Hirano","year":"2020","unstructured":"Hirano I, Dellon ES, Hamilton JD, et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology. 2020;158(1):111-22.e10.","journal-title":"Gastroenterology"},{"issue":"26","key":"2573_CR22","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475\u201385.","journal-title":"N Engl J Med"},{"issue":"10039","key":"2573_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S, Castro M, Corren J, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016;388(10039):31\u201344.","journal-title":"Lancet"},{"key":"2573_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1152\/ajplung.00089.2003","volume":"285","author":"HC Atherton","year":"2003","unstructured":"Atherton HC, Jones G, Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures MAP kinase and phosphatidylinositol 3-kinase regulation. Am J Physiol Lung Cell Mol Physiol. 2003;285:730\u20139.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"2573_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2020.04.015","volume":"18","author":"I Jun","year":"2020","unstructured":"Jun I, Kim BR, Park SY, et al. Interleukin-4 stimulates lipogenesis in meibocytes by activating the STAT6\/PPARgamma signaling pathway. Ocul Surf. 2020;18(4):575\u201382.","journal-title":"Ocul Surf"},{"issue":"6","key":"2573_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.18240\/ijo.2022.06.23","volume":"15","author":"MM Wilson","year":"2022","unstructured":"Wilson MM, Roberts PK, Daniell M. Dupilumab-associated ulcerative keratitis. Int J Ophthalmol. 2022;15(6):1020\u20132.","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"2573_CR27","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/bjd.16330","volume":"178","author":"JP Thyssen","year":"2018","unstructured":"Thyssen JP. Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with demodex and increased interleukin-17 levels? Br J Dermatol. 2018;178(5):1220.","journal-title":"Br J Dermatol"},{"issue":"10","key":"2573_CR28","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jdcr.2019.07.020","volume":"5","author":"FSA de Beer","year":"2019","unstructured":"de Beer FSA, Bakker DS, Haeck I, et al. Dupilumab facial redness: positive effect of itraconazole. JAAD Case Rep. 2019;5(10):888\u201391.","journal-title":"JAAD Case Rep"},{"issue":"9","key":"2573_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IJG.0000000000000069","volume":"24","author":"K Takakuwa","year":"2015","unstructured":"Takakuwa K, Hamanaka T, Mori K, et al. Atopic glaucoma: clinical and pathophysiological analysis. J Glaucoma. 2015;24(9):662\u20138.","journal-title":"J Glaucoma"},{"issue":"12","key":"2573_CR30","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.4103\/1673-5374.339500","volume":"17","author":"D Chen","year":"2022","unstructured":"Chen D, Peng C, Ding XM, et al. Interleukin-4 promotes microglial polarization toward a neuroprotective phenotype after retinal ischemia\/reperfusion injury. Neural Regen Res. 2022;17(12):2755\u201360.","journal-title":"Neural Regen Res"},{"key":"2573_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54257","volume":"9","author":"T Baba","year":"2020","unstructured":"Baba T, Miyazaki D, Inata K, et al. Role of IL-4 in bone marrow driven dysregulated angiogenesis and age-related macular degeneration. Elife. 2020;9:e54257.","journal-title":"Elife"},{"key":"2573_CR32","doi-asserted-by":"publisher","first-page":"9402198","DOI":"10.1155\/2017\/9402198","volume":"2017","author":"H Wu","year":"2017","unstructured":"Wu H, Hwang DK, Song X, Tao Y. Association between aqueous cytokines and diabetic retinopathy stage. J Ophthalmol. 2017;2017:9402198.","journal-title":"J Ophthalmol"},{"issue":"1","key":"2573_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/0301-4738.151464","volume":"63","author":"VV Chernykh","year":"2015","unstructured":"Chernykh VV, Varvarinsky EV, Smirnov EV, Chernykh DV, Trunov AN. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy. Indian J Ophthalmol. 2015;63(1):33\u20136.","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"2573_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1507\/endocrj.K06-054","volume":"53","author":"T Yamada","year":"2006","unstructured":"Yamada T, Komiya I, Miyahara Y, et al. Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves\u2019 disease. Endocr J. 2006;53(6):783\u20138.","journal-title":"Endocr J"},{"issue":"27","key":"2573_CR35","doi-asserted-by":"publisher","first-page":"18296","DOI":"10.1074\/jbc.M603484200","volume":"281","author":"B Chen","year":"2006","unstructured":"Chen B, Tsui S, Boeglin WE, Douglas RS, Brash AR, Smith TJ. Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines. J Biol Chem. 2006;281(27):18296\u2013306.","journal-title":"J Biol Chem"},{"issue":"3B","key":"2573_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1590\/S0004-282X2008000500013","volume":"66","author":"SV Alves-Leon","year":"2008","unstructured":"Alves-Leon SV, Pimentel ML, Sant\u2019Anna G, Malfetano FR, Estrada CD, Quirico-Santos T. Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica. Arq Neuropsiquiatr. 2008;66(3B):678\u201384.","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"2573_CR37","first-page":"124","volume":"3","author":"N Seyfizadeh","year":"2014","unstructured":"Seyfizadeh N, Kazemi T, Farhoudi M, et al. Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis. Am J Clin Exp Immunol. 2014;3(3):124\u20139.","journal-title":"Am J Clin Exp Immunol"},{"issue":"1","key":"2573_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0962280211403604","volume":"22","author":"GN Noren","year":"2013","unstructured":"Noren GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22(1):57\u201369.","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"2573_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","volume":"75","author":"K Bihan","year":"2020","unstructured":"Bihan K, Lebrun-Vignes B, Funck-Brentano C, Salem JE. Uses of pharmacovigilance databases: an overview. Therapie. 2020;75(6):591\u20138.","journal-title":"Therapie"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02573-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02573-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02573-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:18:20Z","timestamp":1692112700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02573-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02573-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}